SRI International And Telik Announce Exclusive License For SRI To Develop Autoimmune And Inflammatory Disease Drug ... Medical News Today Fri, 09 Feb 2007 0:13 AM PST SRI International, an independent nonprofit research and development organization, and Telik, Inc. (Nasdaq: TELK) today announced that they have signed an exclusive license agreement under which SRI will conduct preclinical studies of a Telik drug candidate for the treatment of multiple sclerosis and other autoimmune and inflammatory diseases. [click link for full article] |
Nutra Pharma Announces Shareholder Conference Call to Discuss Recent News and Progress RedNova Fri, 09 Feb 2007 8:17 AM PST Nutra Pharma Corp. (OTCBB: NPHC), a biotechnolo |
Smokin' medicine: Supporters believe marijuana's medicinal value is worth all the battles Colorado Springs Independent Thu, 08 Feb 2007 3:16 PM PST James and Lisa Masters were preparing to take their daughters fishing on the morning of Aug. 2, 2006, when two social workers and two police officers knocked on their door. |
Health ministers meet to tackle wait times CBC Thu, 08 Feb 2007 1:28 PM PST Health ministers from across Canada are meeting in Toronto on Thursday and Friday to hear local and international experts on how to reduce wait times in the health-care system. |
Keep cats away from bird flu areas, UN advises
CBC Thu, 08 Feb 2007 12:01 PM PST
Cats can become infected with a deadly strain of bird flu and as a precaution, the animals should be kept away from areas where the virus has been found in birds, a UN agency said Thursday
0 Comments:
Post a Comment
<< Home